MedTrace Logo

Automated Lamellar Keratectomy in Symptomatic Patients With Bullous Keratopathy

NCT00654888 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2008-04-11

No results posted yet for this study

Summary

To relieve pain in patients with symptomatic bullous keratopathy (BK) until keratoplasty and in patients without visual prediction.

The automated lamellar keratectomy represents a alternative in treatment of pain in symptomatic patients with BK.

Conditions

  • Corneal Disease

Interventions

PROCEDURE

ALK (automated lamellar keratectomy)

ALK is performed with a microkeratome, to make a free cap.

DRUG

Mitomycin

mitomycin 0,02%, 30 seconds after ALK

Sponsors & Collaborators

  • Federal University of São Paulo

    lead OTHER

Principal Investigators

  • Eliana D Gonçalves, MD · Federal University of São Paulo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-03-31
Primary Completion
2006-03-31
Completion
2008-02-29

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00654888 on ClinicalTrials.gov